COVID-19, neurovascular thrombotic problem and short summary on blood coagulation disorder: a brief review

Abstract

COVID-19 is the present global public health problem. This respiratory viral infection can manifest atypical presentation including neurological presentations. An important neurological problem in COVID-19 is neurovascular thrombosis. The basic pathogenesis of thrombosis in neurological system is explainable by the basic principle of thrombohemostasis. A hypercoagulability is a possible problem seen in some COVID-19 cases. In this brief review, the authors summarize venous and arterial thrombosis of neurovascular system as a complication of COVID-19. The updated pathophysiology of COVID-associated blood coagulation disorder is discussed. In addition, consideration regarding new COVID-19 vaccine related thrombotic adverse event is also raised.

The association of pleural effusion and pulmonary embolism

“…2 Vaccines might induce abnormal immunity or high blood viscosity and result in thrombotic event. 2 There is also a chance of coincidence due to a background medical problem or concurrent medial disorder. 2,3 It is necessary to rule out the other possible causes for final conclusion on the vaccine-induced thrombotic event.…”